Target intelligence / Profile preview

Family with sequence similarity 83 member F (FAM83F)

Target
FAM83F
Molecular classification
Other (FAM83 family protein), Pseudo-phospholipase D (pseudo-PLD) domain-containing protein, CK1α-interacting protein
01

Overview

Family with sequence similarity 83 member F (FAM83F) is a vertebrate-specific protein of the FAM83 family, defined by the conserved N-terminal DUF1669 domain, which possesses a pseudo-phospholipase D (PLD)-like motif but does not have PLD catalytic activity[2][4]. FAM83F localizes primarily to the plasma membrane and interacts selectively with casein kinase 1 alpha (CK1α), mediating canonical Wnt signalling and regulating CK1α subcellular localization[1][2]. Overexpression of FAM83F activates Wnt signalling, promoting cell proliferation, cell cycle progression, and inhibiting apoptosis in cancer cells, while knockout or loss attenuates these pathways and increases sensitivity to DNA damage, correlating with impaired autophagy and cellular degradation mechanisms[5][6]. High levels of FAM83F are linked to tumor progression and poor clinical outcomes in several cancers, especially lung adenocarcinoma and cervical cancer, making it a candidate therapeutic target and biomarker in oncology[4][5][6].

Other names
FAM83Fprotein FAM83FFamily with sequence similarity 83 member FFAM83F protein
02

Mechanism of action

Inhibition of Wnt/β-catenin signalling pathway through antagonists such as XAV939[5]

03

Biological functions

Signal transduction (canonical Wnt signalling)Cell proliferationCell cycle progressionApoptosis (inhibition)DNA damage response (stabilization of p53)Autophagy/lysosomal processes
04

Disease associations

Cancer (linked to oncogenesis in glioma, lung cancer, oesophageal cancer, thyroid cancer, cervical cancer, especially highly expressed in lung adenocarcinoma and cervical cancer)Tumor progression and poor prognosisSensitivity to genotoxic stress
05

Safety considerations

Unknown; insufficient data on specific safety concerns or therapeutic challenges associated with targeting FAM83F
06

Interacting drugs

XAV939 (Wnt/β-catenin inhibitor)
07

Biomarkers

High FAM83F expression is a potential biomarker for poor prognosis in lung adenocarcinoma[4] and cervical cancer[5]

Beyond the preview

Go deeper on Family with sequence similarity 83 member F (FAM83F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 83 member F (FAM83F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call